Future directions for this work include further characterization of EYA1, CSMD3, FGFR3, and PCDH15 in prostate cancer metastases and the roles of oxidative phosphorylation and FGFR3 in prostate cancer health disparities. This evidence concerns the gene CSMD3 and prostate carcinoma.